S
Suvoda
Suvoda Interactive Response Technology (IRT/IWRS) is a reimagined randomization and trial supply management system
About Suvoda
Suvoda is a specialized company that provides software solutions for managing complex clinical trials. The company operates in the healthcare and pharmaceutical sectors, focusing on clients such as pharmaceutical companies, biotech firms, and clinical research organizations. Suvoda's primary product is an Interactive Response Technology (IRT) system, which helps manage various aspects of clinical trials, including patient randomization, drug supply management, and trial data collection.
The market Suvoda operates in is highly specialized and regulated, requiring robust and flexible solutions to handle the intricacies of clinical trials. The company's software is designed to be modular, meaning it can be quickly adapted and implemented for different types of studies, even those with complex requirements. This modularity allows for rapid startup times, sometimes as short as four weeks, which is a significant advantage in the fast-paced world of clinical research.
Suvoda's business model revolves around providing software as a service (SaaS). Clients pay for access to the IRT system, which includes ongoing support and updates. The company also offers additional services such as virtual trial solutions, which have become increasingly important due to the COVID-19 pandemic. These solutions include direct-to-patient shipping, allowing trials to continue even when in-person visits are not possible.
Revenue is generated through subscription fees for the software, as well as fees for additional services and support. By offering a flexible, reliable, and quick-to-implement solution, Suvoda helps its clients manage the complexities of clinical trials more efficiently, ultimately speeding up the process of bringing new treatments to market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Conshohocken, United States
- Employees
- 1,300
- Open positions
- 43
- Dealroom signal
- 90.9/100
- Industry
- Health
- Sector
- Health, Clinical, Hard Tech, Health It
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Apr 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Dec 2019 | $40M | $160M | LLR Partners | — |
Growth signals
Latest recorded traffic for Suvoda is 150K monthly website visits, up 0% over the last three months. Suvoda's team grew 4.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
LLR Partners
Other known investors1 additional known investor
University of Nottingham Innovation Park
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Suvoda on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Suvoda’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







